Australia’s medical cannabis market is on a continuous incline, with 6,000+ patients gaining approval for the country’s Special Access Scheme (SAS) Category B pathway as of September. This indicates...

During the month of July, in excess of 5,500 patients were approved to receive unapproved medicinal cannabis products in Australia. These figures, which come courtesy of Australia’s Therapeutic Goods...